Phase 1 Study in Malaria Naïve Adults of BSAM2/Alhydrogel®+CPG 7909, a Blood Stage Vaccine against P. falciparum Malaria

A Phase 1 dose escalating study was conducted in malaria naïve adults to assess the safety, reactogenicity, and immunogenicity of the blood stage malaria vaccine BSAM2/Alhydrogel®+ CPG 7909. BSAM2 is a combination of the FVO and 3D7 alleles of recombinant AMA1 and MSP1(42), with equal amounts by wei...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Ruth D., Wu, Yimin, Martin, Laura B., Shaffer, Donna, Miura, Kazutoyo, Aebig, Joan, Orcutt, Andrew, Rausch, Kelly, Zhu, Daming, Mogensen, Anders, Fay, Michael P., Narum, David L., Long, Carole, Miller, Louis, Durbin, Anna P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464250/
https://www.ncbi.nlm.nih.gov/pubmed/23056238
http://dx.doi.org/10.1371/journal.pone.0046094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464250/
https://www.ncbi.nlm.nih.gov/pubmed/23056238
http://dx.doi.org/10.1371/journal.pone.0046094

Ejemplares similares